Market Cap
$174.70 M
+$18.14 M+11.59%
Wed, 27 Nov 2024 22:27:57 GMT
Summary:
Inhibikase Therapeutics market capitalization is currently $174.70 million, with a rise of +$18.14 million (+11.59%) during the most recent trading day. Over the past year, it has increased by +$169.33 million (+3152.28%). IKT market cap is now -13.33% below its all-time high of $201.58 million.IKT Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | +11.6% | +11.6% | 0.0% | - |
| 1 m1 month | +9.6% | +7.3% | - | - |
| 3 m3 months | +1571.8% | +85.7% | - | - |
| 6 m6 months | +1060.3% | +36.8% | - | - |
| ytdytd | +2177.4% | +109.7% | - | - |
| 1 y1 year | +3152.3% | +198.8% | +988.3% | - |
| 5 y5 years | - | - | - | - |
IKT Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $202 M | -13.3% | $132 M | +32.0% |
| 3 m | 3 months | $202 M | -13.3% | $8.58 M | +1935.3% |
| 6 m | 6 months | $202 M | -13.3% | $8.31 M | +2003.4% |
| 1 y | 1 year | $202 M | -13.3% | $5.37 M | +3152.3% |
| 3 y | 3 years | $202 M | -13.3% | $4.34 M | +3923.7% |
| 5 y | 5 years | $202 M | -13.3% | $4.34 M | +3923.7% |
| alltime | all time | $202 M | -13.3% | $4.34 M | +3923.7% |
Inhibikase Therapeutics Market Cap History
| Date | Value |
|---|---|
| 2024 | $174.70 M(+2177.4%) |
| 2023 | $7.67 M(-39.2%) |
| Date | Value |
|---|---|
| 2022 | $12.61 M(-65.9%) |
| 2021 | $36.98 M(-46.7%) |
| 2020 | $69.35 M |
FAQ
- What is Inhibikase Therapeutics market capitalization?
- What is the all time high market cap for Inhibikase Therapeutics?
- What is IKT market capitalization year-to-date change?
- What is Inhibikase Therapeutics market cap year-on-year change?
What is Inhibikase Therapeutics market capitalization?
The current market cap of IKT is $174.70 M
What is the all time high market cap for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high market capitalization is $201.58 M
What is IKT market capitalization year-to-date change?
Inhibikase Therapeutics market capitalization has changed by +$167.03 M (+2177.41%) since the beginning of the year
What is Inhibikase Therapeutics market cap year-on-year change?
Over the past year, IKT market capitalization has changed by +$169.33 M (+3152.28%)